P

Inventor

NOUJAIM ANTOINE

CA12 patents
⚠️ This page may combine multiple inventors who share the name “NOUJAIM ANTOINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VIREXX MEDICAL CORP

3 patents
US6960352B2Nov 1, 2005

Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent

VIREXX MEDICAL CORP22 citations89
US6887474B1May 3, 2005

Compositions and methods for producing vascular occlusion

VIREXX MEDICAL CORP15 citations82
US7390488B2Jun 24, 2008

Compositions and methods for producing vascular occlusion

VIREXX MEDICAL CORP1 citations59

PALADIN LABS INC

3 patents
US8007805B2Aug 30, 2011

Chimeric antigens for breaking host tolerance to foreign antigens

PALADIN LABS INC35 citations88
US8029803B2Oct 4, 2011

Chimeric antigens for eliciting an immune response

PALADIN LABS INC8 citations81
US8025873B2Sep 27, 2011

Chimeric antigens for eliciting an immune response

PALADIN LABS INC13 citations80

GEORGE RAJAN

2 patents
US8465745B2Jun 18, 2013

Chimeric antigens for eliciting an immune response

GEORGE RAJAN7 citations78
US8637477B2Jan 28, 2014

Antigenic compositions and use of same in the targeted delivery of nucleic acids

GEORGE RAJAN3 citations58

ALTAREX INC

1 patent
US6689355B2Feb 10, 2004

Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells

ALTAREX INC37 citations84

ALTAREX MEDICAL CORP

1 patent
US7318921B2Jan 15, 2008

Therapeutic compositions that alter the immune response

ALTAREX MEDICAL CORP3 citations59

IMBIOTECHNOLOGIES LTD

1 patent
US7947282B2May 24, 2011

Methods of treatment using vascular occlusion in combination therapies

IMBIOTECHNOLOGIES LTD3 citations55

VIREXX MEDCIAL CORP

1 patent
US7387994B2Jun 17, 2008

Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent

VIREXX MEDCIAL CORP4 citations55